• Title/Summary/Keyword: 밸리데이션

Search Result 48, Processing Time 0.03 seconds

Study of application method for Medical device in packaging validation (의료기기 포장 밸리데이션 적용 방안)

  • (사)한국포장협회
    • The monthly packaging world
    • /
    • s.247
    • /
    • pp.53-73
    • /
    • 2013
  • 한국건설생활환경시험연구원은 2012년 2월 15일부터 11월 30일까지 식품의약품안전청에서 시행한 용역연구개발과제의 일환으로 '의료기기 포장 밸리데이션 적용 방안'을 연구했다. 본 고에서는 연구 보고서 내용 중 일부를 소개하도록 한다.

  • PDF

HPLC-UVD method validation for quantitative analysis of camelliaside A in hot-water extract of soybean (Glycine max L.) leaves (콩잎 열수추출물의 지표성분인 camelliaside A의 정량분석을 위한 HPLC-UVD 분석법 밸리데이션)

  • Kim, Jeong Ho;Lee, Seung Hwan;Moon, Si Won;Park, Ki Hun
    • Journal of Applied Biological Chemistry
    • /
    • v.65 no.3
    • /
    • pp.195-202
    • /
    • 2022
  • Soybean (Glycine max L.) leaves have been researched as functional food stuff actively, but there is no validation method to control quality of soybean leaves (SL). In this study, we annotated seven kaempferol derivatives to confirm camelliaside A as index metabolite in SL using UHPLC-ESI-TOF-MS. HPLC-UVD validation method of camelliaside A in hot-water extract of SL was established according to validation guideline of functional foods from the Ministry of Food and Safety of Korea. The HPLC-UVD method was validated with reliable parameters for examining specificity, accuracy, precision, limit of detection and quantification and linearity. The established method gave the suitable ranges to qunatitate camelliaside A from the hot-water extract of soybean leaves.

포장과 법률 - '의약품 제조 및 품질관리에 관한 규정' 일부개정

  • (사)한국포장협회
    • The monthly packaging world
    • /
    • s.317
    • /
    • pp.100-111
    • /
    • 2019
  • 식품의약품안전처는 가입한 의약품실사상호협력기구(PIC/S)의 규정 변경 사항을 '의약품 제조 및 품질관리에 관한 규정'([별표13])에 반영해 국제 조화하기 위하여 '의약품 제조 및 품질관리에 관한 규정'을 일부개정한다고 밝혔다. 주요 내용은 ▲공정밸리데이션 방법의 선택적 적용, ▲규제의 합리적 개선, ▲포장공정 밸리데이션, 세척 밸리데이션 구체화 등 조문 정비 등이다. 다음에 '의약품 제조 및 품질관리에 관한 규정' 일부개정의 상세한 내용을 살펴보도록 한다.

  • PDF

Necessity of high-performance liquid chromatography validation in good laboratory practice systems (비임상시험관리기준 시스템에서 고성능액체크로마토그래피 분석법 정확도 검증의 필요성)

  • Su Bin Yang;Changyul Kim
    • Journal of the Korean Applied Science and Technology
    • /
    • v.41 no.2
    • /
    • pp.172-187
    • /
    • 2024
  • In good laboratory practice (GLP), analytical method validation prior to toxicity testing is important in terms of concentration setting and sample preparation. The testing agency performed validation of the two requested test substances using high-performance liquid chromatography (HPLC), and as a result, the analysis satisfied the criteria for specificity, system suitability, linearity, intra-day reproducibility, homogeneity, stability, concentration analysis, and quality control. The method was established and validated. However, the content of standard substances in the test report of the requesting institution was found to be 1.34 and 1.17 times higher than the results of the testing institution, confirming that deriving results through validation of analysis methods suitable for GLP is important in terms of securing reliability and stability.

Validation and Content Analysis of Putrescine in the Venom of Honeybee (Apis mellifera L.) (서양종꿀벌 일벌독에 함유된 putrescine 밸리데이션 및 함량 분석)

  • Choi, Hong Min;Kim, Hyo Young;Kim, Se Gun;Han, Sang Mi
    • Korean journal of applied entomology
    • /
    • v.60 no.3
    • /
    • pp.263-268
    • /
    • 2021
  • The venom of honeybees (Apis mellifera L.) is used to treat many diseases because of its anti-inflammatory and analgesic effects. Bee venom consists of several biologically active molecules and exhibits remarkable anti-cancer effects. However, biological amines, which exhibit diverse functionality such as anti-inflammatory and antibacterial effects, have not been previously reported in bee venom. In this study, we determined the content of putrescine in bee venom by using ultra-performance liquid chromatography. The specificity, accuracy, and precision of the assay were assessed, and the assay validated. The linearity of the putrescine assay was r ≥ 0.99, indicating a moderate level of putrescine in the bee venom. The limit of detection and limit of quantification were both 0.9 ㎍/mL, while the rate of recovery was 96.4%-99.9%. The relative standard deviation (RSD) of the intra-day precision and inter-day precision of the putrescine assay were 0.16% - 0.23% and 0.09% - 0.36%, respectively, with the RSD ≤ 5% indicating excellent precision. Thus, the linearity, limit of detection, limit of quantification, and recovery rate of the putrescine assay were satisfactory. The analysis of the bee venom showed that the putrescine content was 3.1 ± 0.09 mg/g. This study provides fundamental data on putrescine content in bee venom, which will prove useful in further studies of its bioactivity.

The Quantification and Validation of Loxoprofen using Near-infrared(NIR) Spectrum Method (근적외부스펙트럼 측정법을 이용한 록소프로펜의 정량화 및 밸리데이션)

  • Choi, Sung-Up
    • Journal of the Korea Academia-Industrial cooperation Society
    • /
    • v.15 no.1
    • /
    • pp.396-401
    • /
    • 2014
  • In this study, we used NIR spectrum method instead of conventional HPLC method to shorten the analysis and manufacturing time of the loxoprofen products. Loxoprofen mixtures with other pharmaceutical additives were prepared and evaluated by the NIR spectrometer and the HPLC system. Validation of both methods was performed for specificity, accuracy and precision. NIR spectrometer method was validated and revealed proper results for the in-process quality control in the pharmaceutical field. In conclusion, NIR spectrometry can be replaced by HPLC method.

A Study on the Application of Risk Management for Medical Device Software Test (의료기기 소프트웨어 테스트 위험관리 적용 방안 연구)

  • Kim, S.H.;Lee, jong-rok;Jeong, Dong-Hun;Park, Hui-Byeong
    • Proceedings of the Korean Institute of Information and Commucation Sciences Conference
    • /
    • 2012.10a
    • /
    • pp.495-497
    • /
    • 2012
  • Development of application risk management for medical device software test. First, Through questionnaires, Medical device manufacturers, Analysis of software validation and risk management status. Second, Analyzed by comparing the difference between black box testing and white box testing. Third, After analyzing the potential for software analysis tools using code derived factors were quantified, Finally, Medical device risk management process so that it can be applied to build the framework by FMEA(Failure Mode and Effect Analysis) technique. Through this Difficult to build software validation and risk management processes for manufacturers to take advantage of support in medical device GMP(Good Manufacture Practice).

  • PDF